Vitamin D2 vs D3: The Supplement Label Detail Researchers Say May Matter

Vitamin D has one of those supplement labels that looks simple until it doesn’t. You see “vitamin D” on the front of the bottle, maybe a dose in IU, and it feels like the form is just fine print.

But a new review of randomized trials makes that fine print worth reading. Researchers reported that vitamin D2 supplementation was associated with lower measured 25-hydroxyvitamin D3, or 25(OH)D3, compared with controls. That’s the D3-specific blood marker - not a diagnosis, not a symptom score, just one piece of the vitamin D status picture (PubMed).

And here’s the calmer version: this is not a story about vitamin D being dangerous, or about D2 suddenly becoming poison. It doesn’t mean anyone should stop a prescription. It does mean the D2-versus-D3 label detail is more than trivia, especially if you’re buying your own supplements or taking high doses without much guidance.

D2 and D3 are different forms, not just different names

#

Vitamin D2 is ergocalciferol. Vitamin D3 is cholecalciferol. Both are used in supplements and fortified foods, and both can affect vitamin D status. D2 is often associated with fungi or plant-type sources, such as UV-exposed mushrooms, while D3 is the form your skin makes after UVB exposure and is also found in some animal-derived foods and supplements. Vegan D3 from lichen may be available too, which is worth knowing if you’re plant-based and reading labels carefully (NIH ODS; FDA).

So no, D2 isn’t “fake” vitamin D. That’s too blunt, and it misses the useful point.

The useful point is that D2 and D3 don’t behave identically in the body. For a related evidence-boundary example, see our calcium and vitamin D bone-health evidence review. Clinical reviews describe differences in binding protein affinity, conversion, half-life, and clearance. In plainer English: the body may handle the two forms differently after you swallow them (Cleveland Clinic Journal of Medicine).

What the new review actually found

#

The new Nutrition Reviews paper looked at randomized controlled trials of vitamin D2 supplementation and serum 25(OH)D3. It included 20 randomized-trial articles, with 11 suitable for meta-analysis. In pooled data, D2 supplementation was linked with lower 25(OH)D3 compared with controls at the end of trials, with a weighted mean difference of -17.99 nmol/L. A second analysis, looking at absolute change from baseline, found a smaller but still statistically significant reduction of -9.25 nmol/L (PubMed).

That’s a real blood-marker finding. It also has a fence around it.

The review doesn’t prove that D2 causes fractures, infections, fatigue, immune disease, or any other clinical outcome. It doesn’t show that a person taking prescribed D2 is being harmed. It says the D3-specific marker went down in pooled trial evidence. More technical than the headline, yes. Also more honest.

And this is where supplement stories often get bent out of shape. A marker-level shift becomes a scary command: stop this, switch that, buy the other bottle. The evidence here doesn’t support that leap.

Why D3 often gets the edge

#

If you’re buying an over-the-counter vitamin D supplement and your clinician hasn’t told you otherwise, D3 often has the stronger evidence for raising vitamin D status.

Several reviews have found that D3 generally raises total 25-hydroxyvitamin D, the main blood marker clinicians use for vitamin D status, more effectively than D2. A 2012 review favored D3 in its pooled results, especially with larger intermittent dosing, though daily dosing looked less clear. A 2021 review also supported greater efficacy for D3, and a 2024 daily D2-versus-D3 review again found that study design and factors such as BMI can complicate the comparison (PubMed; PubMed; PubMed).

So, should everyone switch to D3 tomorrow? Not quite.

Some people are prescribed D2. Some use D2 because of vegan preferences, fortification choices, cost, access, or a specific clinical plan. Some are being monitored with labs, and some have medical reasons not to improvise. For those readers, the safer move is boring but important: ask the prescriber why that form was chosen and whether D2, D3, total 25(OH)D, or the D2/D3 fractions matter in your case.

The immune angle is interesting, but not a promise

#

There is another reason researchers care about D2 versus D3: the two forms may not have identical downstream effects.

A human transcriptome study found overlapping but different immune-gene responses after D2 and D3 supplementation. In that analysis, D3, but not D2, showed stimulation of type I and type II interferon-related activity (Frontiers in Immunology / PMC).

But that’s not the same as saying D3 prevents colds, flu, COVID, or bacterial infections. It doesn’t. Gene-expression work can point to biological plausibility (useful, genuinely), but it’s not a clinical outcomes trial. If a supplement ad turns that into “take D3 for immunity,” it’s stretching well past what this evidence can carry.

Read the label before you read the hype

#

Here’s the practical part. Turn the bottle around and look for ergocalciferol, which is D2, or cholecalciferol, which is D3. If supplement panels feel murky, our Supplement Facts label guide is a useful companion. Check the dose in both IU and micrograms if both are listed. Also check whether you’re doubling up through a multivitamin, a bone-health product, a fortified milk alternative, or another supplement you forgot about (easy to do with stacked wellness products).

And if the front label only says “vitamin D,” don’t stop there. The supplement facts panel should tell you the form.

For a standard over-the-counter choice, D3 often makes sense because it tends to raise vitamin D status more effectively. But that doesn’t turn D2 into trash. It means the form is one detail to weigh alongside dose, diet, medical history, lab results, cost, vegan preferences, calcium intake, and clinician advice.

More vitamin D is not the smarter answer

#

One bad read of this research would be: D3 looks better, so take a lot more D3. Please don’t make that jump.

The U.S. recommended daily allowance is 600 IU per day for most adults through age 70 and 800 IU per day for adults over 70. The adult tolerable upper intake level is 4,000 IU per day, which is a ceiling rather than a target (NIH ODS).

That ceiling matters because vitamin D toxicity is rare but serious, and it usually comes from excessive supplement use rather than normal food or usual sun exposure. The central problem is too much calcium in the blood - the sort of lab abnormality you don’t want to create with a wellness habit - with possible symptoms including nausea, vomiting, weakness, frequent urination, bone pain, kidney stones, and kidney problems (Mayo Clinic; FDA).

And the 2024 Endocrine Society guidance pushes back against broad disease-prevention supplement thinking in many healthy adults. In plain terms, more vitamin D isn’t automatically better, and routine testing or supplementation isn’t a universal health chore for every healthy adult (Endocrine Society).

Who should ask before changing anything

#

If you’re taking prescription D2, don’t stop it because of a headline. Ask the clinician who prescribed it whether the new evidence changes anything for your situation.

And if you’re pregnant or breastfeeding, older, treating a diagnosed deficiency, managing osteoporosis, dealing with kidney disease, malabsorption, bariatric surgery history, hyperparathyroidism, sarcoidosis or another granulomatous disease, high calcium, kidney stones, or a complicated medication list, don’t DIY the switch-and-dose decision.

Medication users should be careful too. Our supplement-drug interaction disclosure guide covers why the full medication list matters. NIH ODS lists orlistat, statins, steroids, and thiazide diuretics as examples where vitamin D intake or status should be discussed with healthcare providers. Thiazide diuretics plus vitamin D can increase hypercalcemia risk in vulnerable groups, especially when calcium is also in the mix (NIH ODS).

So yes, bring the bottle. Bring the lab result if you have one. Ask what form you’re taking, what marker is being followed, and what dose makes sense for your actual risk profile. Not very glamorous, I know. But safer.

Bottom line

#

The new D2 finding is worth taking seriously, but not dramatically.

Vitamin D2 and D3 are not identical. D3 generally has better evidence for raising vitamin D status, and a recent review found that D2 supplementation was associated with lower measured 25(OH)D3 in pooled randomized-trial data. But the clinical meaning still needs more research, and the finding doesn’t prove that D2 is dangerous or useless.

So the practical takeaway is pretty simple: check whether your supplement is D2 or D3, avoid high-dose self-prescribing, don’t stop prescribed vitamin D without asking, and get clinician or pharmacist input if you’re deficient, pregnant, older, on interacting medicines, or dealing with kidney, calcium, bone, or absorption issues.

Not dramatic. Just better label reading.